Product Code: RP-ID-10013016 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013016
Market Overview:
Global Biological Implants Market Size Study, By Product (Autografts, Allografts, Xenografts), By Application (Cardiovascular Orthopedic, Dental, & Dermal Implants), By Mode of Administration (Injectable, Surgical) and Regional Forecasts, 2017-2025
Global Biological Implants industry valued approximately USD 5.46 billion in 2016 is anticipated to grow with a healthy growth rate of more than 7.60% over the forecast period 2017-2025. The key driver of the market are technological advancements in biological implant, growing competition amongst leading market player and development in composite grafting.
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Product:
 Autografts
 Allografts
 Xenografts
Application:
 Cardiovascular implants
 Orthopedic implants
 Other soft tissue implants
Mode of Adminstration:
 Surgical biological implants
 Injectable biological implant
Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market are Integra LifeSciences Corporation, Edwards LifeSciences Corporation, NuVasive, Inc, Stryker Corporation, RTI Surgical, Acelity, Medtronic, BioPolymer GmbH & Co. KG, Vericel, Aplhatec Spine Inc, Baxter International, and CryoLife. The companies are spending a lot on their research and development programs to keep up with the dynamically changing technologies in the market. Acquisitions and effective mergers are one of the expansion strategies taken by the key manufacturers.
Target Audience of the Biological Implants Market Study
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Please note that owing to the criticality of the Biological Implants market and rapidly changing market attributes, we are in the middle of updating the report. The final report may require 2 to 3 working days post-confirmation in order to cater to the most recent updates.
NuVasive, Inc
Edward LifeSciences Corporation
Stryker Corporation
LifeCell Corporation
RTI Surgical, Inc
BioPolymer GmbH & Co. KG
Johnson & Johnson
DePuy Synthes, Inc.
Baxter International, Inc.
Vericel Corporation
Alphatec Spine, Inc
CryoLife
Maxigen Biotech, Inc.
Related Reports
Proof of Quality & Reliability
